How many years can you take Talazoparib for the longest time?

Talazoparib (Talazoparib) is a drug used to treat breast and prostate cancer and is a PARP inhibitor. Based on current clinical data and relevant guidelines, the duration of lazopanib use should be determined based on the patient's specific condition and treatment efficacy. In general, treatment cycles with lazopanib can range from several months to several years.

For patients with breast cancer, talazopanib is mainly used to treat BRCA mutation-positive recurrent or metastatic breast cancer For patients with prostate cancer, talazopanib is mainly used in combination with enzalutamide to treat metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene mutations. Before starting to use lazopanib, it is recommended to consult your doctor. They will evaluate the treatment plan based on your specific situation and recommend the most appropriate time to take the medication. The duration of treatment may be affected by a variety of factors, including the progression of the disease, the patient's overall health, and the effectiveness of other treatments.

The original drug of talazopanib has not yet been marketed in China, so it has not been included in medical insurance. The original drug specification of talazopanib listed overseas is 0.25mg*30 capsules, and the price per box may be around RMB 10,000 (the price may fluctuate due to exchange rate effects), which is relatively expensive. There are also cheaper generics of talazopanib overseas. For example, the price of a box of 1mg*30 pills produced by a Laos pharmaceutical factory may be more than 3,000 yuan (the price may fluctuate due to the exchange rate).